Sign In

​​

Funds Managed by Mr. Sailesh Raj Bhan

Show All

Nippon India Large Cap FundAn open ended equity scheme predominantly investing in large cap stocksLatest NAV: 90.0282
(Jun 25 , 2026)



Product label

This product is suitable for investors who are seeking*:

  • Long term capital growth.
  • Investment predominantly into equity and equity related instruments of large cap companies.

*Investors should consult their investment advisers if in doubt about whether the product is suitable for them

Nippon India Multi Cap FundMulti Cap Fund - An open ended equity scheme investing across large cap, mid cap, small cap stocksLatest NAV: 302.2561
(Jun 25 , 2026)



Nippon India Multi Cap Fund
Fund / Benchmark(Value of ₹10,000 invested)1 Year3 Year5 YearSince Inception
Amount in ₹Returns (%)Amount in ₹Returns (%)Amount in ₹Returns (%)Amount in ₹Returns (%)
NAV as on May 29, 2026: ₹296.5834
Nippon India Multi Cap Fund - Regular​
Inception Date : Mar 28, 2005
Nippon India Multi Cap Fund10,0660.6616,51818.2324,55319.692,96,58617.35
B:NIFTY 500 Multicap 50:25:25 TRI10,1431.4315,77716.4319,64614.47NANA
AB:BSE Sensex TRI9,279-7.2312,3577.3215,2768.851,52,70413.73
NAV as on May 29, 2026: ₹327.5908
Nippon India Multi Cap Fund - Direct Inception Date : Jan 1, 2013
Nippon India Multi Cap Fund10,1441.4416,91019.1625,49620.6073,87816.08
B:NIFTY 500 Multicap 50:25:25 TRI10,1431.4315,77716.4319,64614.4764,97614.97
AB:BSE Sensex TRI9,279-7.2312,3577.3215,2768.8545,32111.93
Fund Manager : Sailesh Raj Bhan (Since Mar 2005)
NA has been mentioned as the benchmark data for corresponding period is not available.

PERFORMANCE OF OTHER OPEN ENDED SCHEMES MANAGED BY FUND MANAGER: Sailesh Raj Bhan

Scheme Name/sCAGR %
1 Year Return 3 Years Return5 Years Return
Regular SchemeDirect SchemeBenchmarkRegular SchemeDirect SchemeBenchmarkRegular SchemeDirect SchemeBenchmark
Nippon India Pharma Fund5.786.7310.4922.5823.6926.2612.7813.8014.50
Nippon India Large Cap Fund-1.51-0.70-2.3014.0915.0611.1715.0216.0011.04

Note:

a. Mr. Sailesh Raj Bhan manages 3 open-ended schemes of Nippon India Mutual Fund.

b. In case the number of schemes managed by a fund manager is more than six, in the performance data of other schemes, the top 3 and bottom 3 schemes managed by fund manager has been provided herein.

c. Period for which scheme’s performance has been provided is computed basis last day of the month-end preceding the date of advertisement.

d. Different plans shall have a different expense structure.

The performance provided herein is of growth plan unless,

(1)-The Scheme does not offer any Plans/Options. The performance details are provided at Scheme level using IDCW Reinvestment NAV's.

(2)-Co-Fund Manager

(3)-Assistant Fund Manager

(4)- The Scheme Returns are inclusive of the impact of Segregation of Portfolio...

TRI - Total Returns Index reflects the returns on the index arising from (a) constituent stock price movements and (b) dividend receipts from constituent index stocks, thereby showing a true picture of returns.

The performance of the equity scheme is benchmarked to the Total Return variant of the Index.

Mr. Sailesh Raj Bhan has been managing Nippon India Pharma Fund since Jun 2004, Nippon India Multi Cap Fund since Mar 2005, Nippon India Large Cap Fund since Aug 2007

Past performance may or may not be sustained in future and the same may not necessarily provide the basis for comparison with other investments. Returns for 1 year and above are compounded annualized (CAGR) and returns less than 1 year are simple annualized basis. 6 months simple annualized returns are provided for the schemes that are in existence for more than 6 months but have not completed 1 year. IDCW (if any) are assumed to be reinvested at the prevailing NAV. In case of Nippon India ETF Nifty 1D Rate Liquid BeES, returns are based on gross IDCW per unit declared by the Fund. Bonus (if any) declared has been adjusted. Face value of schemes is ` 10 per unit, except for the schemes as specified here. Face Value of Nippon India Liquid Fund, Nippon India Money Market Fund, Nippon India Ultra Short Duration Fund, Nippon India Low Duration Fund and Nippon India ETF Nifty 1D Rate Liquid BeES is ` 1000 per unit. Face value of Nippon India ETF Nifty Next 50 Junior BeES is ` 1.25 per unit. Face value of Nippon India Overnight Fund is ` 100 per unit. Face Value of Nippon India ETF Nifty 50 BeES, Nippon India ETF Nifty Bank BeES, Nippon India ETF Nifty PSU Bank BeES, Nippon India ETF Nifty 50 Value 20, Nippon India ETF Hang Seng BeES, Nippon India ETF Gold BeES is ` 1 per unit. In case, the start/end date of the concerned period is non-business day, NAV of the previous date is considered for computation of returns. Performance details of closed ended and interval schemes are not provided since these are not comparable with other schemes. Different plans shall have a different expense structure. The performance details provided herein are of Growth plan.








Product label

This product is suitable for investors who are seeking*:

  • Long term capital growth.
  • Investment in equity and equity related securities.

*Investors should consult their investment advisers if in doubt about whether the product is suitable for them

Nippon India Pharma FundAn open ended equity scheme investing in pharma sectorLatest NAV: 550.8208
(Jun 25 , 2026)



Nippon India Pharma Fund
Fund / Benchmark(Value of ₹10,000 invested)1 Year3 Year5 YearSince Inception
Amount in ₹Returns (%)
Amount in ₹Returns (%)Amount in ₹Returns (%)Amount in ₹Returns (%)
NAV as on May 29, 2026: ₹533.2115
Nippon India Pharma Fund - Regular​​
Inception Date : Jun 5, 2004
Nippon India Pharma Fund10,5765.7818,40922.5818,23912.785,33,20719.82
B:BSE Healthcare TRI11,04610.4920,11526.2619,66914.502,43,49815.62
AB:BSE Sensex TRI9,279-7.2312,3577.3215,2768.852,06,61914.76
NAV as on May 29, 2026: ₹598.5008
Nippon India Pharma Fund - Direct
Inception Date : Jan 1, 2013
Nippon India Pharma Fund10,6716.7318,91023.6919,07713.8086,07317.41
B:BSE Healthcare TRI11,04610.4920,11526.2619,66914.5062,24914.60
AB:BSE Sensex TRI9,279-7.2312,3577.3215,2768.8545,32111.93
Fund Manager : Sailesh Raj Bhan (Since Jun 2004)
As TRI data is not available since Since Inception of the scheme, benchmark performance is calculated using composite CAGR of BSE HC PRI values from date 04-Jun-2004 to date 23-Aug-2004 and TRI values since date 23-Aug-2004

PERFORMANCE OF OTHER OPEN ENDED SCHEMES MANAGED BY FUND MANAGER: Sailesh Raj Bhan

​Scheme Name/sCAGR %
1 Year Return 3 Years Return5 Years Return
Regular SchemeDirect SchemeBenchmarkRegular SchemeDirect SchemeBenchmarkRegular SchemeDirect SchemeBenchmark
Nippon India Multi Cap Fund0.661.441.4318.2319.1616.4319.6920.6014.47
Nippon India Large Cap Fund-1.51-0.70-2.3014.0915.0611.1715.0216.0011.04

Note:

a.Mr. Sailesh Raj Bhan manages 3 open-ended schemes of Nippon India Mutual Fund.

b. In case the number of schemes managed by a fund manager is more than six, in the performance data of other schemes, the top 3 and bottom 3 schemes managed by fund manager has been provided herein.

c. Period for which schemes performance has been provided is computed basis last day of the month-end preceding the date of advertisement.

d. Different plans shall have a different expense structure.

The performance provided herein is of growth plan unless,

(1)-The Scheme does not offer any Plans/Options. The performance details are provided at Scheme level using IDCW Reinvestment NAV's.

(2)-Co-Fund Manager

(3)-Assistant Fund Manager

(4)- The Scheme Returns are inclusive of the impact of Segregation of Portfolio...

TRI - Total Returns Index reflects the returns on the index arising from (a) constituent stock price movements and (b) dividend receipts from constituent index stocks, thereby showing a true picture of returns.

The performance of the equity scheme is benchmarked to the Total Return variant of the Index.

Mr. Sailesh Raj Bhan has been managing Nippon India Pharma Fund since Jun 2004, Nippon India Multi Cap Fund since Mar 2005, Nippon India Large Cap Fund since Aug 2007

Past performance may or may not be sustained in future and the same may not necessarily provide the basis for comparison with other investments. Returns for 1 year and above are compounded annualized (CAGR) and returns less than 1 year are simple annualized basis. 6 months simple annualized returns are provided for the schemes that are in existence for more than 6 months but have not completed 1 year. IDCW (if any) are assumed to be reinvested at the prevailing NAV. In case of Nippon India ETF Nifty 1D Rate Liquid BeES, returns are based on gross IDCW per unit declared by the Fund. Bonus (if any) declared has been adjusted. Face value of schemes is ` 10 per unit, except for the schemes as specified here. Face Value of Nippon India Liquid Fund, Nippon India Money Market Fund, Nippon India Ultra Short Duration Fund, Nippon India Low Duration Fund and Nippon India ETF Nifty 1D Rate Liquid BeES is ` 1000 per unit. Face value of Nippon India ETF Nifty Next 50 Junior BeES is ` 1.25 per unit. Face value of Nippon India Overnight Fund is ` 100 per unit. Face Value of Nippon India ETF Nifty 50 BeES, Nippon India ETF Nifty Bank BeES, Nippon India ETF Nifty PSU Bank BeES, Nippon India ETF Nifty 50 Value 20, Nippon India ETF Hang Seng BeES, Nippon India ETF Gold BeES is ` 1 per unit. In case, the start/end date of the concerned period is non-business day, NAV of the previous date is considered for computation of returns. Performance details of closed ended and interval schemes are not provided since these are not comparable with other schemes. Different plans shall have a different expense structure. The performance details provided herein are of Growth plan.








Product label

This product is suitable for investors who are seeking*:

  • Long term capital growth.
  • investment predominantly in equity and equity related Securities of pharma & other associated companies.

*Investors should consult their investment advisers if in doubt about whether the product is suitable for them

Get the app